Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Independent Market Research Ranks Sysmex in Hematology Instruments

By LabMedica International staff writers
Posted on 17 Mar 2009
In IMV's 2008 ServiceTrak annual report Sysmex America (Mundelein, IL, USA) was ranked best in hematology instrument reliability and industry for the ninth consecutive year. More...
Sysmex also ranked first in 21 of the 30 survey factors, including all five Original Equipment Manufacturer (OEM) service performance factors and all five manufacturer and instrument performance factors. The IMV ServiceTrak survey respondents include clinical laboratory department supervisors, laboratory managers, and technologists chosen at random from hospitals of varying sizes from across the country.

For customer satisfaction, Sysmex hematology instruments also ranked first in MD Buyline's January 2009 User Satisfaction Ratings. MD Buyline survey respondents include technologists and clinicians from hospitals and clinical reference laboratories located throughout the United States. MD Buyline is a comprehensive database of information on healthcare products.

"Regardless of the healthcare industry's economic concerns, we know our customers must provide high quality care for their patients. As a healthcare partner to many of the nation's healthcare facilities, we are honored that our hematology instruments have met their needs in reliability and performance expectations," said John Kershaw, president, Sysmex America, Inc.

Instrument reliability also impacts clinical laboratory performance metrics such as results turnaround time and repeat rate. Switching to backup analyzers could create issues with shifting normal ranges and consistency of results used in patient trending analysis. "Therefore, clinical laboratories will want to assess their instrument capability relative to their effect on service lines, care pathways, medical errors, and patient flow," added Mr. Kershaw.

Sysmex America, Inc., the U.S. headquarters of Sysmex Corporation (Kobe, Japan), distributes and supports automated in vitro diagnostic hematology, coagulation, and urinalysis analyzers, reagents, and information systems for laboratories and healthcare facilities throughout the Western Hemisphere. The company focuses on extending the boundaries of diagnostic science while providing the management information tools that make a real difference in clinical and operational results for people worldwide.

Related Links:

Sysmex America



Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Neonatal Heel Incision Device
Tenderfoot
New
Drug Testing Assays
Atellica DT 250 Analyzer
New
Nucleic Acid Purification Instrument
QIAsymphony Connect
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Researchers from the Department of Chemistry at Aarhus University have developed and tested a new technology that can identify and measure the concentration of pharmaceuticals in under 10 minutes. Today, this process takes up to an hour. That is critical waiting time for patients suffering from a stroke. (Image Credit: Aarhus University)

Point-of-Care Blood Test Could Speed Treatment Decisions in Acute Stroke

Minutes can shape treatment decisions in emergency stroke care, particularly when physicians need to know whether a patient is taking anticoagulants before administering clot-dissolving therapy.... Read more

Microbiology

view channel
Image: The clearance also broadens QIAstat-Dx\'s infectious disease testing menu in the U.S., which already includes panels for respiratory and gastrointestinal infections, as well as meningitis and encephalitis (Photo courtesy of Qiagen)

One-Hour Molecular Panel Expands Bloodstream Infection Testing for Gram-Negative Pathogens

Bloodstream infections can progress rapidly and lead to sepsis, organ failure, and death. In the United States, about 1.7 million adults develop sepsis each year, and at least 350,000 die during hospitalization... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.